Vol 3, No 2 (2011)
Mol Cell Pharmacol
Table of Contents
PharmSights
| Effects of Histone Deacetylase Inhibitors on Modulating H3K4 Methylation Marks – A Novel Cross-Talk Mechanism between Histone-Modifying Enzymes | Abstract PDF |
| Po-Hsien Huang, Christoph Plass, Ching-Shih Chen | 39-43 |
| Functional Roles of Endothelin ETB Receptor in the Vascular Disease and Its Sex Difference | Abstract PDF |
| Kento Kitada, Mamoru Ohkita, Yasuo Matsumura | 45-52 |
| Bladder Selectivity of Imidafenacin, a Novel Antimuscarinic Agent Developed to Treat Overactive Bladder | Abstract PDF |
| Shizuo Yamada, Akira Yoshida, Masaki Ogoda, Yusuke Fuchihata, Shiori Kuraoka, Hideo Tsukada, Tsuyoshi Anraku | 53-58 |
| Precise Synchrony by Mutual Inhibition: Experiments Vindicate Theory | Abstract PDF |
| Hang Hu, Yunyong Ma, Ariel Agmon | 59-65 |
| Novel Insights into Beneficial Consequences of Statins in Sepsis: Anti-inflammatory and Anti-apoptotic Mechanisms | Abstract PDF |
| Kengo Tomita, Ken-ichi Takano, Hiroki Yokoo, Yuichi Hattori | 67-74 |
FDA Corner
| FDA Approves First Generic Version of Cholesterol-Lowering Drug Lipitor | Abstract PDF |
| 75 |
| FDA Approves Erwinaze to Treat a Form of Leukemia | Abstract PDF |
| 75-76 |
| FDA Approves Cialis to Treat Benign Prostatic Hyperplasia | Abstract PDF |
| 76 |
| FDA Approves Remicade to Treat Ulcerative Colitis in Children 6 Years and Older | Abstract PDF |
| 76-77 |
Our partner: Crossroads Pharmacy 2800 Hwy 101, Rogersville, AL 35652 LumiText Publishing, P.O. Box 774, Ellicott City, MD 21041 Copyright © 2008 LumiText Publishing. All rights reserved.